Abstract
Glutamate dehydrogenase (GDH) catalyzes the reversible deamination of l-glutamate to α-ketoglutarate and ammonia. In mammals, GDH contributes to important processes such as amino acid and carbohydrate metabolism, energy production, ammonia management, neurotransmitter recycling and insulin secretion. In humans, two isoforms of GDH are found, namely hGDH1 and hGDH2, with the former being ubiquitously expressed and the latter found mainly in brain, testis and kidney. These two iso-enzymes display highly divergent allosteric properties, especially concerning their basal activity, ADP activation and GTP inhibition. On the other hand, both enzymes are thought to predominantly localize in the mitochondrial matrix, even though alternative localizations have been proposed. To further study the subcellular localization of the two human iso-enzymes, we created HEK293 cell lines stably over-expressing hGDH1 and hGDH2. In these cell lines, immunofluorescence and enzymatic analyses verified the overexpression of both hGDH1 and hGDH2 iso-enzymes, whereas subcellular fractionation followed by immunoblotting showed their predominantly mitochondrial localization. Given that previous studies have only indirectly compared the subcellular localization of the two iso-enzymes, we co-expressed them tagged with different fluorescent dyes (green and red fluorescent protein for hGDH1 and hGDH2, respectively) and found them to co-localize. Despite the wealth of information related to the functional properties of hGDH1 and hGDH2 and the availability of the hGDH1 structure, there is still an ongoing debate concerning their metabolic role and their involvement in disease processes. Data on the localization of hGDHs, as the ones presented here, could contribute to better understanding of the function of these important human enzymes.
Similar content being viewed by others
References
Strecker HJ (1953) Glutamic dehydrogenase. Arch Biochem Biophys 46(1):128–140. https://doi.org/10.1016/0003-9861(53)90176-3
Hudson R, Daniel R (1993) L-glutamate dehydrogenases: distribution, properties and mechanism. Comp Biochem Physiol B 106(4):767–792
Plaitakis A, Zaganas I (2001) Regulation of human glutamate dehydrogenases: implications for glutamate, ammonia and energy metabolism in brain. J Neurosci Res 66(5):899–908. https://doi.org/10.1002/jnr.10054
Hutson SM, Islam MM, Zaganas I (2011) Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways. Neurochem Int 59(4):518–524. https://doi.org/10.1016/j.neuint.2011.05.001
Zaganas I, Spanaki C, Plaitakis A (2012) Expression of human GLUD2 glutamate dehydrogenase in human tissues: functional implications. Neurochem Int 61(4):455–462. https://doi.org/10.1016/j.neuint.2012.06.007
Li M, Li C, Allen A, Stanley CA, Smith TJ (2014) Glutamate dehydrogenase: structure, allosteric regulation, and role in insulin homeostasis. Neurochem Res 39(3):433–445. https://doi.org/10.1007/s11064-013-1173-2
Fahien LA, MacDonald MJ (2011) The complex mechanism of glutamate dehydrogenase in insulin secretion. Diabetes 60(10):2450–2454. https://doi.org/10.2337/db10-1150
McKenna M, Stridh M, McNair L, Sonnewald U, Waagepetersen H, Schousboe A (2016) Glutamate oxidation in astrocytes: roles of glutamate dehydrogenase and aminotransferases. J Neurosci Res 94(12):1561–1571. https://doi.org/10.1002/jnr.23908
McKenna MC (2011) Glutamate dehydrogenase in brain mitochondria: do lipid modifications and transient metabolon formation influence enzyme activity? Neurochem Int 59(4):525–533. https://doi.org/10.1016/j.neuint.2011.07.003
Spanaki C, Plaitakis A (2012) The role of glutamate dehydrogenase in mammalian ammonia metabolism. Neurotox Res 21(1):117–127. https://doi.org/10.1007/s12640-011-9285-4
Lorin S, Tol MJ, Bauvy C, Strijland A, Poüs C, Verhoeven AJ, Codogno P, Meijer AJ (2013) Glutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy. Autophagy 9(6):850–860. https://doi.org/10.4161/auto.24083
Shashidharan P, Michaelidis TM, Robakis NK, Kresovali A, Papamatheakis J, Plaitakis A (1994) Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene. J Biol Chem 269(24):16971–16976
Zaganas IV, Kanavouras K, Borompokas N, Arianoglou G, Dimovasili C, Latsoudis H, Vlassi M, Mastorodemos V (2014) The odyssey of a young gene: structure–function studies in human glutamate dehydrogenases reveal evolutionary-acquired complex allosteric regulation mechanisms. Neurochem Res 39(3):471–486. https://doi.org/10.1007/s11064-014-1251-0
Burki F, Kaessmann H (2004) Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. Nat Genet 36:1061. https://doi.org/10.1038/ng1431 https://www.nature.com/articles/ng1431#supplementary-information
Varki A (2004) How to make an ape brain. Nat Genet 36:1034. https://doi.org/10.1038/ng1004-1034
Shashidharan P, Plaitakis A (2014) The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease. Neurochem Res 39(3):460–470. https://doi.org/10.1007/s11064-013-1227-5
Zaganas I, Spanaki C, Karpusas M, Plaitakis A (2002) Substitution of Ser for Arg-443 in the regulatory domain of human housekeeping (GLUD1) glutamate dehydrogenase virtually abolishes basal activity and markedly alters the activation of the enzyme by adp and l-Leucine. J Biol Chem 277(48):46552–46558. https://doi.org/10.1074/jbc.M208596200
Zaganas I, Plaitakis A (2002) Single amino acid substitution (G456A) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the cooperative behavior of the enzyme. J Biol Chem 277(29):26422–26428. https://doi.org/10.1074/jbc.M200022200
Shashidharan P, Clarke DD, Ahmed N, Moschonas N, Plaitakis A (1997) Nerve tissue-specific human glutamate dehydrogenase that is thermolabile and highly regulated by ADP. J Neurochem 68(5):1804–1811. https://doi.org/10.1046/j.1471-4159.1997.68051804.x
Zaganas I, Kanavouras K, Mastorodemos V, Latsoudis H, Spanaki C, Plaitakis A (2009) The human GLUD2 glutamate dehydrogenase: localization and functional aspects. Neurochem Int 55(1):52–63. https://doi.org/10.1016/j.neuint.2009.03.001
Engel PC (2014) Glutamate dehydrogenases: the why and how of coenzyme specificity. Neurochem Res 39(3):426–432. https://doi.org/10.1007/s11064-013-1089-x
Bailey J, Bell ET, Bell JE (1982) Regulation of bovine glutamate dehydrogenase. The effects of pH and ADP. J Biol Chem 257(10):5579–5583
Yudkoff M (1997) Brain metabolism of branched-chain amino acids. Glia 21 (1):92–98. https://doi.org/10.1002/(SICI)1098-1136(199709)21:1%3C92::AID-GLIA10%3E3.0.CO;2-W
Cooper AJL (2012) The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem Res 37(11):2439–2455. https://doi.org/10.1007/s11064-012-0803-4
Smith HQ, Li C, Stanley CA, Smith TJ (2017) Glutamate dehydrogenase, a complex enzyme at a crucial metabolic branch point. Neurochem Res. https://doi.org/10.1007/s11064-017-2428-0
Marcaggi P, Coles JA (2001) Ammonium in nervous tissue: transport across cell membranes, fluxes from neurons to glial cells, and role in signalling. Prog Neurobiol 64(2):157–183. https://doi.org/10.1016/S0301-0082(00)00043-5
Adeva MM, Souto G, Blanco N, Donapetry C (2012) Ammonium metabolism in humans. Metab Clin Exp 61(11):1495–1511. https://doi.org/10.1016/j.metabol.2012.07.007
Zaganas I, Pajęcka K, Wendel Nielsen C, Schousboe A, Waagepetersen HS, Plaitakis A (2013) The effect of pH and ADP on ammonia affinity for human glutamate dehydrogenases. Metab Brain Dis 28(2):127–131. https://doi.org/10.1007/s11011-013-9382-6
Tsacopoulos M, Poitry-Yamate CL, Poitry S (1997) Ammonium and glutamate released by neurons are signals regulating the nutritive function of a glial cell. J Neurosci 17(7):2383–2390
Spinelli JB, Yoon H, Ringel AE, Jeanfavre S, Clish CB, Haigis MC (2017) Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science 358(6365):941–946. https://doi.org/10.1126/science.aam9305
Li M, Li C, Allen A, Stanley CA, Smith TJ (2012) The structure and allosteric regulation of mammalian glutamate dehydrogenase. Arch Biochem Biophys 519(2):69–80. https://doi.org/10.1016/j.abb.2011.10.015
Mastorodemos V, Zaganas I, Spanaki C, Bessa M, Plaitakis A (2005) Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. J Neurosci Res 79(1–2):65–73. https://doi.org/10.1002/jnr.20353
Kanavouras K, Mastorodemos V, Borompokas N, Spanaki C, Plaitakis A (2007) Properties and molecular evolution of human GLUD2 (neural and testicular tissue-specific) glutamate dehydrogenase. J Neurosci Res 85(5):1101–1109. https://doi.org/10.1002/jnr.21197
Plaitakis A, Metaxari M, Shashidharan P (2000) Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms. J Neurochem 75(5):1862–1869. https://doi.org/10.1046/j.1471-4159.2000.0751862.x
Smith TJ, Schmidt T, Fang J, Wu J, Siuzdak G, Stanley CA (2002) The structure of apo human glutamate dehydrogenase details subunit communication and allostery. J Mol Biol 318(3):765–777. https://doi.org/10.1016/S0022-2836(02)00161-4
Peterson PE, Pierce J, Smith TJ (1997) Crystallization and characterization of bovine liver glutamate dehydrogenase. J Struct Biol 120(1):73–77. https://doi.org/10.1006/jsbi.1997.3899
Peterson PE, Smith TJ (1999) The structure of bovine glutamate dehydrogenase provides insights into the mechanism of allostery. Structure 7(7):769–782. https://doi.org/10.1016/S0969-2126(99)80101-4
Smith TJ, Peterson PE, Schmidt T, Fang J, Stanley CA (2001) Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation 1 Edited by I. A. Wilson. J Mol Biol 307(2):707–720. https://doi.org/10.1006/jmbi.2001.4499
Li M, Li C, Allen A, Stanley CA, Smith TJ (2011) The structure and allosteric regulation of glutamate dehydrogenase. Neurochem Int 59(4):445–455. https://doi.org/10.1016/j.neuint.2010.10.017
Mastorodemos V, Kanavouras K, Sundaram S, Providaki M, Petraki Z, Kokkinidis M, Zaganas I, Logothetis DE, Plaitakis A (2015) Side-chain interactions in the regulatory domain of human glutamate dehydrogenase determine basal activity and regulation. J Neurochem 133(1):73–82. https://doi.org/10.1111/jnc.13019
Banerjee S, Schmidt T, Fang J, Stanley CA, Smith TJ (2003) Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation. Biochemistry 42(12):3446–3456. https://doi.org/10.1021/bi0206917
Spanaki C, Kotzamani D, Petraki Z, Drakos E, Plaitakis A (2015) Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues. Mol Cell Endocrinol 415:1–11. https://doi.org/10.1016/j.mce.2015.07.020
Spanaki C, Zaganas I, Kleopa KA, Plaitakis A (2010) Human GLUD2 glutamate dehydrogenase is expressed in neural and testicular supporting cells. J Biol Chem 285(22):16748–16756. https://doi.org/10.1074/jbc.M109.092999
Spanaki C, Kotzamani D, Petraki Z, Drakos E, Plaitakis A (2014) Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues. Neurochem Res 39(3):500–515. https://doi.org/10.1007/s11064-013-1235-5
Hull J, Usmari Moraes M, Brookes E, Love S, Conway ME (2018) Distribution of the branched-chain α-ketoacid dehydrogenase complex E1α subunit and glutamate dehydrogenase in the human brain and their role in neuro-metabolism. Neurochem Int 112:49–58. https://doi.org/10.1016/j.neuint.2017.10.014
Spanaki C, Kotzamani D, Kleopa K, Plaitakis A (2016) Evolution of GLUD2 glutamate dehydrogenase allows expression in human cortical neurons. Mol Neurobiol 53(8):5140–5148. https://doi.org/10.1007/s12035-015-9429-2
Nissen JD, Lykke K, Bryk J, Stridh MH, Zaganas I, Skytt DM, Schousboe A, Bak LK, Enard W, Pääbo S, Waagepetersen HS (2017) Expression of the human isoform of glutamate dehydrogenase, hGDH2, augments TCA cycle capacity and oxidative metabolism of glutamate during glucose deprivation in astrocytes. Glia 65(3):474–488. https://doi.org/10.1002/glia.23105
Salganicoff L, Robertis ED (1965) Subcellular distribution of the enzymes of the glutamic acid, glutamine and γ-aminobutyric acid cycles in rat brain*. J Neurochem 12(4):287–309. https://doi.org/10.1111/j.1471-4159.1965.tb06766.x
Aoki C, Milner TA, Berger SB, Sheu KFR, Blass JP, Pickel VM (1987) Glial glutamate dehydrogenase: ultrastructural localization and regional distribution in relation to the mitochondrial enzyme, cytochrome oxidase. J Neurosci Res 18(2):305–318. https://doi.org/10.1002/jnr.490180207
Rothe F, Brosz M, Storm-Mathisen J (1994) Quantitative ultrastructural localization of glutamate dehydrogenase in the rat cerebellar cortex. Neuroscience 62(4):1133–1146. https://doi.org/10.1016/0306-4522(94)90349-2
Colon AD, Plaitakis A, Perakis A, Berl S, Clarke DD (1986) Purification and characterization of a soluble and a particulate glutamate dehydrogenase from rat brain. J Neurochem 46(6):1811–1819. https://doi.org/10.1111/j.1471-4159.1986.tb08500.x
Rajas F, Rousset B (1993) A membrane-bound form of glutamate dehydrogenase possesses an ATP-dependent high-affinity microtubule-binding activity. Biochem J 295(2):447–455. https://doi.org/10.1042/bj2950447
Lee W, Shin S, Cho S, Park J (1999) Purification and characterization of glutamate dehydrogenase as another isoprotein binding to the membrane of rough endoplasmic reticulum. J Cell Biochem 76(2):244–253
Pragnya P, Mrutyunjay S, Divya S, Shashibhal Matacharan P, Madan Mohan C, Jogeswar Satchidananda P (2011) Characterization of nuclear glutamate dehydrogenase of chicken liver and brain. Protein Pept Lett 18(12):1194–1203. https://doi.org/10.2174/092986611797642698
di Prisco G, Banay-Schwartz M, Strecker HJ (1968) Glutamate dehydrogenase in nuclear and mitochondrial fractions of rat liver. Biochem Biophys Res Commun 33(4):606–612. https://doi.org/10.1016/0006-291X(68)90339-2
Lai J, Sheu K, Kim Y, Clarke D, Blass J (1986) The subcellular localization of glutamate dehydrogenase (GDH): is GDH a marker for mitochondria in brain? Neurochem Res 11(5):733–744
Plaitakis A, Kalef-Ezra E, Kotzamani D, Zaganas I, Spanaki C (2017) The glutamate dehydrogenase pathway and its roles in cell and tissue biology in health and disease. Biology 6(1):11
Mastorodemos V, Kotzamani D, Zaganas I, Arianoglou G, Latsoudis H, Plaitakis A (2009) Human GLUD1 and GLUD2 glutamate dehydrogenase localize to mitochondria and endoplasmic reticulum. Biochem Cell Biol 87(3):505–516. https://doi.org/10.1139/O09-008
Rosso L, Marques AC, Reichert AS, Kaessmann H (2008) Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive darwinian selection. PLOS Genet 4(8):e1000150. https://doi.org/10.1371/journal.pgen.1000150
Kalef-Ezra E, Kotzamani D, Zaganas I, Katrakili N, Plaitakis A, Tokatlidis K (2016) Import of a major mitochondrial enzyme depends on synergy between two distinct helices of its presequence. Biochem J 473(18):2813–2829. https://doi.org/10.1042/bcj20160535
Ebrahimi-Fakhari D, Saffari A, Wahlster L, Di Nardo A, Turner D, Lewis Tommy L, Conrad C, Rothberg Jonathan M, Lipton Jonathan O, Kölker S, Hoffmann Georg F, Han M-J, Polleux F, Sahin M (2016) Impaired mitochondrial dynamics and mitophagy in neuronal models of tuberous sclerosis complex. Cell Rep 17(4):1053–1070. https://doi.org/10.1016/j.celrep.2016.09.054
Karnati S, Lüers G, Pfreimer S, Baumgart-Vogt E (2013) Mammalian SOD2 is exclusively located in mitochondria and not present in peroxisomes. Histochem Cell Biol 140(2):105–117. https://doi.org/10.1007/s00418-013-1099-4
Lin C-C, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T, Choudhary V, Hobbs R, Liu L-K, Lee P-H, Outeda P, Zhou F, Restifo NP, Watnick T, Kawano H, Horie S, Prinz W, Xu H, Menezes LF, Germino GG (2018) A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep 8(1):2743. https://doi.org/10.1038/s41598-018-20856-6
Carobbio S, Ishihara H, Fernandez-Pascual S, Bartley C, Martin-Del-Rio R, Maechler P (2004) Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets. Diabetologia 47(2):266–276. https://doi.org/10.1007/s00125-003-1306-2
Tanizawa Y, Nakai K, Sasaki T, Anno T, Ohta Y, Inoue H, Matsuo K, Koga M, Furukawa S, Oka Y (2002) Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimulated insulin secretion. Identification and characterization of a GLUD1 gene mutation and insulin secretion studies with MIN6 cells overexpressing the mutant glutamate dehydrogenase. Diabetes 51(3):712–717. https://doi.org/10.2337/diabetes.51.3.712
Anno T, Uehara S, Katagiri H, Ohta Y, Ueda K, Mizuguchi H, Moriyama Y, Oka Y, Tanizawa Y (2004) Overexpression of constitutively activated glutamate dehydrogenase induces insulin secretion through enhanced glutamate oxidation. Am J Physiol-Endocrinol Metab 286(2):E280–E285. https://doi.org/10.1152/ajpendo.00380.2003
Bao X, Pal R, Hascup KN, Wang Y, Wang W-T, Xu W, Hui D, Agbas A, Wang X, Michaelis ML, Choi I-Y, Belousov AB, Gerhardt GA, Michaelis EK (2009) Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability. J Neurosci 29(44):13929–13944. https://doi.org/10.1523/jneurosci.4413-09.2009
Li Q, Guo S, Jiang X, Bryk J, Naumann R, Enard W, Tomita M, Sugimoto M, Khaitovich P, Pääbo S (2016) Mice carrying a human GLUD2 gene recapitulate aspects of human transcriptome and metabolome development. Proc Natl Acad Sci 113(19):5358–5363. https://doi.org/10.1073/pnas.1519261113
Wang X, Bao X, Pal R, Agbas A, Michaelis EK (2010) Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. BMC Genom 11(1):360. https://doi.org/10.1186/1471-2164-11-360
Michaelis EK, Wang X, Pal R, Bao X, Hascup KN, Wang Y, Wang WT, Hui D, Agbas A, Choi IY, Belousov A, Gerhardt GA (2011) Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression. Neurochem Int 59(4):473–481. https://doi.org/10.1016/j.neuint.2011.03.003
Hascup KN, Bao X, Hascup ER, Hui D, Xu W, Pomerleau F, Huettl P, Michaelis ML, Michaelis EK, Gerhardt GA (2011) Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum. ASN Neuro 3(2):AN20110005. https://doi.org/10.1042/an20110005
Choi I-Y, Lee P, Wang W-T, Hui D, Wang X, Brooks WM, Michaelis EK (2014) Metabolism changes during aging in the hippocampus and striatum of Glud1 (glutamate dehydrogenase 1) transgenic mice. Neurochem Res 39(3):446–455. https://doi.org/10.1007/s11064-014-1239-9
Wang X, Patel ND, Hui D, Pal R, Hafez MM, Sayed-Ahmed MM, Al-Yahya AA, Michaelis EK (2014) Gene expression patterns in the hippocampus during the development and aging of Glud1(glutamate dehydrogenase 1) transgenic and wild type mice. BMC Neurosci 15(1):37. https://doi.org/10.1186/1471-2202-15-37
Plaitakis A, Zaganas I, Spanaki C (2013) Deregulation of glutamate dehydrogenase in human neurologic disorders. J Neurosci Res 91(8):1007–1017. https://doi.org/10.1002/jnr.23176
Kelly A, Stanley C (2001) Disorders of glutamate metabolism. Dev Disabil Res Rev 7(4):287–295
Palladino AA, Stanley CA (2010) The hyperinsulinism/hyperammonemia syndrome. Rev Endocr Metab Disord 11(3):171–178. https://doi.org/10.1007/s11154-010-9146-0
Stanley CA, Lieu YK, Hsu BYL, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338(19):1352–1357. https://doi.org/10.1056/nejm199805073381904
Tran C, Konstantopoulou V, Mecjia M, Perlman K, Mercimek-Mahmutoglu S, Kronick Jonathan B (2015) Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene. J Pediatr Endocrinol Metab. https://doi.org/10.1515/jpem-2014-0441
Aka S, Alanay Y, Boodhansingh K, Stanley C, Semiz S (2016) Seizures and diagnostic difficulties in hyperinsulinism-hyperammonemia syndrome. Turk J Pediatr 58(5):541–544. https://doi.org/10.24953/turkjped.2016.05.014
Ninković D, Sarnavka V, Bašnec A, Ćuk M, Ramadža Danijela P, Fumić K, Kušec V, Santer R, Barić I (2016) Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature. J Pediatr Endocrinol Metab. https://doi.org/10.1515/jpem-2016-0086
Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K (2013) Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 168(4):557–564. https://doi.org/10.1530/eje-12-0673
Corrêa-Giannella ML, Freire DS, Cavaleiro AM, Fortes MAZ, Giorgi RR, Pereira MAA (2012) Hyperinsulinism/hyperammonemia (HI/HA) syndrome due to a mutation in the glutamate dehydrogenase gene. Arq Bras Endocrinol Metabol 56:485–489
Aso K, Okano Y, Takeda T, Sakamoto O, Ban K, Iida K, Yamano T, Shintaku H (2011) Spectrum of glutamate dehydrogenase mutations in Japanese patients with congenital hyperinsulinism and hyperammonemia syndrome. Osaka City Med J 57(1):1–9
Diao C, Chen S, Xiao X, Wang T, Sun X, Wang O, Song H, Zhang Y, Yu M, Zhang Q, Wang H (2010) Two unrelated chinese patients with hyperinsulinism/hyperammonemia (HI/HA) syndrome due to mutations in glutamate dehydrogenase gene. J Pediatr Endocrinol Metab. https://doi.org/10.1515/JPEM.2010.23.7.733
Kapoor RR, Flanagan SE, Fulton P, Chakrapani A, Chadefaux B, Ben-Omran T, Banerjee I, Shield JP, Ellard S, Hussain K (2009) Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations. Eur J Endocrinol 161(5):731–735. https://doi.org/10.1530/eje-09-0615
de Lonlay P, Benelli C, Fouque F, Ganguly A, Aral B, Dionisi-Vici C, Touati G, Heinrichs C, Rabier D, Kamoun P, Robert J-J, Stanley C, Saudubray J-M (2001) Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res 50:353. https://doi.org/10.1203/00006450-200109000-00010
Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, Schneppenheim R, Schaub J (2001) Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet 108(1):66–71. https://doi.org/10.1007/s004390000432
Yasuda K, Koda N, Kadowaki H, Ogawa Y, Kimura S, Kadowaki T, Akanuma Y (2001) A Japanese case of congenital hyperinsulinism with hyperammonemia due to a mutation in glutamate dehydrogenase (GLUD1) gene. Intern Med 40(1):32–37. https://doi.org/10.2169/internalmedicine.40.32
Barrosse-Antle M, Su C, Chen P, Boodhansingh KE, Smith TJ, Stanley CA, De León DD, Li C (2017) A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase. Pediatr Diabetes 18(8):911–916. https://doi.org/10.1111/pedi.12507
Snider KE, Becker S, Boyajian L, Shyng SL, MacMullen C, Hughes N, Ganapathy K, Bhatti T, Stanley CA, Ganguly A (2013) Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 98(2):E355–E363. https://doi.org/10.1210/jc.2012-2169
Stanley CA (2009) Regulation of glutamate metabolism and insulin secretion by glutamate dehydrogenase in hypoglycemic children1–4. Am J Clin Nutr 90(3):862S–866S. https://doi.org/10.3945/ajcn.2009.27462AA
Kibbey RG, Choi CS, Lee H-Y, Cabrera O, Pongratz RL, Zhao X, Birkenfeld AL, Li C, Berggren P-O, Stanley C, Shulman GI (2014) Mitochondrial GTP insensitivity contributes to hypoglycemia in hyperinsulinemia hyperammonemia by inhibiting glucagon release. Diabetes 63(12):4218–4229. https://doi.org/10.2337/db14-0783
Andersson LE, Shcherbina L, Al-Majdoub M, Vishnu N, Arroyo CB, Carrara JA, Wollheim CB, Fex M, Mulder H, Wierup N, Spégel P (2017) Glutamine-elicited secretion of glucagon-like peptide 1 (GLP-1) is governed by an activated glutamate dehydrogenase. Diabetes. https://doi.org/10.2337/db16-1441
Göhring I, Mulder H (2012) Glutamate dehydrogenase, insulin secretion, and type 2 diabetes: a new means to protect the pancreatic β-cell? J Endocrinol 212(3):239–242. https://doi.org/10.1530/joe-11-0481
Pournourmohammadi S, Grimaldi M, Stridh MH, Lavallard V, Waagepetersen HS, Wollheim CB, Maechler P (2017) Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: a potential beneficial effect in the pre-diabetic state? Int J Biochem Cell Biol 88:220–225. https://doi.org/10.1016/j.biocel.2017.01.012
Stanley CA (2011) Two genetic forms of hyperinsulinemic hypoglycemia caused by dysregulation of glutamate dehydrogenase. Neurochem Int 59(4):465–472. https://doi.org/10.1016/j.neuint.2010.11.017
De Lonlay P, Giurgea I, Sempoux C, Touati G, Jaubert F, Rahier J, Ribeiro M, Brunelle F, Nihoul-Fékété C, Robert J-J, Saudubray J-M, Stanley C, Bellanné-Chantelot C (2005) Dominantly inherited hyperinsulinaemic hypoglycaemia. J Inherit Metab Dis 28(3):267–276. https://doi.org/10.1007/s10545-005-7057-0
Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, Xiong G, Chen J, Stokes D, Butt YM, Jones PM, Collins HW, Cohen NA, Cohen AS, Nissim I, Smith TJ, Strauss AW, Matschinsky FM, Bennett MJ, Stanley CA (2010) Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem 285(41):31806–31818. https://doi.org/10.1074/jbc.M110.123638
Narayan SB, Master SR, Sireci AN, Bierl C, Stanley PE, Li C, Stanley CA, Bennett MJ (2012) Short-chain 3-hydroxyacyl-coenzyme a dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways. PLoS ONE 7(4):e35048. https://doi.org/10.1371/journal.pone.0035048
Bahi-Buisson N, Roze E, Dionisi C, Escande F, Valayannopoulos V, Feillet F, Heinrichs C (2008) Neurological aspects of hyperinsulinism–hyperammonaemia syndrome. Dev Med Child Neurol 50(12):945–949. https://doi.org/10.1111/j.1469-8749.2008.03114.x
Kelly A, Stanley CA (2008) Neurological aspects in hyperinsulinism-hyperammonaemia syndrome. Dev Med Child Neurol 50(12):888–888. https://doi.org/10.1111/j.1469-8749.2008.03149.x
Nakano K, Kobayashi K, Okano Y, Aso K, Ohtsuka Y (2012) Intractable absence seizures in hyperinsulinism-hyperammonemia syndrome. Pediatr Neurol 47(2):119–122. https://doi.org/10.1016/j.pediatrneurol.2012.04.019
Balasubramaniam S, Kapoor R, Yeow J, Lim P, Flanagan S, Ellard S, Hussain K (2011) Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome. J Pediatr Endocrinol Metab 24(7–8):573–577
Treiman DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42(Suppl 3):8–12
Shetty AK, Upadhya D (2016) GABA-ergic cell therapy for epilepsy: advances, limitations and challenges. Neurosci Biobehav Rev 62:35–47. https://doi.org/10.1016/j.neubiorev.2015.12.014
Levy LM, Hallett M (2002) Impaired brain GABA in focal dystonia. Ann Neurol 51(1):93–101
Malthankar-Phatak GH, De Lanerolle N, Eid T, Spencer DD, Behar KL, Spencer SS, Kim JH, Lai JCK (2006) Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy. Epilepsia 47(8):1292–1299. https://doi.org/10.1111/j.1528-1167.2006.00543.x
Sherwin A, Quesney F, Gauthier S, Olivier A, Robitaille Y, McQuaid P, Harvey C, van Gelder N (1984) Enzyme changes in actively spiking areas of human epileptic cerebral cortex. Neurology 34(7):927–933
Rasgado Lourdes AV, Reyes Guillermo C, Díaz Fernando V (2015) Modulation of brain glutamate dehydrogenase as a tool for controlling seizures. Acta Pharm. https://doi.org/10.1515/acph-2015-0033
Badawi Y, Pal R, Hui D, Michaelis EK, Shi H (2015) Ischemic tolerance in an in vivo model of glutamate preconditioning. J Neurosci Res 93(4):623–632. https://doi.org/10.1002/jnr.23517
Kim AY, Baik EJ (2018) Glutamate dehydrogenase as a neuroprotective target against neurodegeneration. Neurochem Res. https://doi.org/10.1007/s11064-018-2467-1
Kim AY, Jeong K-H, Lee JH, Kang Y, Lee SH, Baik EJ (2017) Glutamate dehydrogenase as a neuroprotective target against brain ischemia and reperfusion. Neuroscience 340:487–500. https://doi.org/10.1016/j.neuroscience.2016.11.007
Hohnholt MC, Andersen VH, Andersen JV, Christensen SK, Karaca M, Maechler P, Waagepetersen HS (2017) Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678x17714680
Plaitakis A, Latsoudis H, Kanavouras K, Ritz B, Bronstein JM, Skoula I, Mastorodemos V, Papapetropoulos S, Borompokas N, Zaganas I, Xiromerisiou G, Hadjigeorgiou GM, Spanaki C (2009) Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson’s disease onset. Eur J Hum Genet 18:336. https://doi.org/10.1038/ejhg.2009.179 https://www.nature.com/articles/ejhg2009179#supplementary-information
Plaitakis A, Caroscio JT (1987) Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 22(5):575–579. https://doi.org/10.1002/ana.410220503
Sorbi S, Tonini S, Giannini E, Piacentini S, Marini P, Amaducci L (1986) Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. Ann Neurol 19(3):239–245. https://doi.org/10.1002/ana.410190304
Plaitakis A (1990) Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: a hypothesis. Ann Neurol 28(1):3–8. https://doi.org/10.1002/ana.410280103
Plaitakis A, Berl S, Yahr MD (1984) Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann Neurol 15(2):144–153. https://doi.org/10.1002/ana.410150206
Plaitakis A, Nicklas WJ, Desnick RJ (1980) Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome. Ann Neurol 7(4):297–303. https://doi.org/10.1002/ana.410070403
Plaitakis A, Flessas P, Natsiou A, Shashidharan P (1993) Glutamate dehydrogenase deficiency in cerebellar degenerations: clinical, biochemical and molecular genetic aspects. Can J Neurol Sci 20(Suppl 3):S109–S116
Burbaeva GS, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS (2005) Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer’s disease patients. Neurochem Res 30(11):1443–1451. https://doi.org/10.1007/s11064-005-8654-x
Jin L, Li D, Alesi Gina N, Fan J, Kang H-B, Lu Z, Boggon Titus J, Jin P, Yi H, Wright Elizabeth R, Duong D, Seyfried Nicholas T, Egnatchik R, DeBerardinis Ralph J, Magliocca Kelly R, He C, Arellano Martha L, Khoury Hanna J, Shin Dong M, Khuri Fadlo R, Kang S (2015) Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27(2):257–270. https://doi.org/10.1016/j.ccell.2014.12.006
Takeuchi Y, Nakayama Y, Fukusaki E, Irino Y (2018) Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion. Biochem Biophys Res Commun 495(1):761–767. https://doi.org/10.1016/j.bbrc.2017.11.088
Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha Y, Li D, Alesi GN, Kang Y, Zhou L, Yu W-M, Magliocca KR, Khuri FR, Qu C-K, Metallo C, Owonikoko TK, Kang S (2018) The PLAG1-GDH1 axis promotes anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer. Mol Cell 69(1):87–99.e87. https://doi.org/10.1016/j.molcel.2017.11.025
Zhang J, Wang G, Mao Q, Li S, Xiong W, Lin Y, Ge J (2016) Glutamate dehydrogenase (GDH) regulates bioenergetics and redox homeostasis in human glioma. Oncotarget 295:799–800
Yang C, Sudderth J, Dang T, Bachoo RG, McDonald JG, DeBerardinis RJ (2009) Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Can Res 69(20):7986–7993. https://doi.org/10.1158/0008-5472.Can-09-2266
Waitkus MS, Pirozzi CJ, Moure CJ, Diplas BH, Hansen LJ, Carpenter AB, Yang R, Wang Z, Ingram BO, Karoly ED, Mohney RP, Spasojevic I, McLendon RE, Friedman HS, He Y, Bigner DD, Yan H (2018) Adaptive evolution of the GDH2 allosteric domain promotes gliomagenesis by resolving IDH1R132H-induced metabolic liabilities. Cancer Res 78(1):36–50. https://doi.org/10.1158/0008-5472.Can-17-1352
Chen R, Nishimura MC, Kharbanda S, Peale F, Deng Y, Daemen A, Forrest WF, Kwong M, Hedehus M, Hatzivassiliou G, Friedman LS, Phillips HS (2014) Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. Proc Natl Acad Sci 111(39):14217–14222. https://doi.org/10.1073/pnas.1409653111
Li M, Allen A, Smith TJ (2007) High throughput screening reveals several new classes of glutamate dehydrogenase inhibitors. Biochemistry 46(51):15089–15102. https://doi.org/10.1021/bi7018783
Zhu M, Fang J, Zhang J, Zhang Z, Xie J, Yu Y, Ruan JJ, Chen Z, Hou W, Yang G, Su W, Ruan BH (2017) Biomolecular interaction assays identified dual inhibitors of glutaminase and glutamate dehydrogenase that disrupt mitochondrial function and prevent growth of cancer cells. Anal Chem 89(3):1689–1696. https://doi.org/10.1021/acs.analchem.6b03849
Acknowledgements
This work would not have been completed without the valuable assistance of Dr. Christina Dimovasili. We would also like to thank Dr. Dimitra Kotzamani and Dr. Maria Savaki for their help with confocal microscopy, Cynthia Manassaki for coordinating the overall project and Rena Skoula for her continuous aid with technical issues. Finally, we cordially acknowledge the vision and inspiration to work in this exciting field of research provided to us by Professor Andreas Plaitakis.
Funding
This work has been supported by intramural grants of the University of Crete, Heraklion, Crete, Greece, through the Special Account for Research - Research Funding Programs: (1) “Structural studies on human glutamate dehydrogenase iso-enzymes” (Grant Code: KA4374), (2) “Knock-out of GLUD1 and GLUD2 genes from human cell lines, using the CRISPR/Cas9 system” (Grant Code: KA4435).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declared that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mathioudakis, L., Bourbouli, M., Daklada, E. et al. Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes. Neurochem Res 44, 170–187 (2019). https://doi.org/10.1007/s11064-018-2575-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-018-2575-y